Table 1. Novel Approaches to Universal ART.
Antiretroviral Drugs |
Less Frequent Administration of Current Oral Drugs |
Tenofovir |
Efavirenz |
New Orally Administered Drug |
EFdA (MK-8591) |
Long-Acting Injectables |
Carbotegravir |
Rilpivirine |
Polymer Implants |
Tenofovir |
EFdA (MK-8591) |
Monoclonal Antibodies |
Broadly Neutralizing Antibodies |
VRC01, VRC01-LS |
3BNC117 |
10-1074 |
Antibodies that Inhibit Cell Entry |
Ibalizumab |
PRO 140 |